About Parataxis Capital
Parataxis Capital is a Financial Services company based in New York (United States) founded in 2019. Parataxis Capital is focused on digital asset investment advisory. It operates on a Professional Services and FinTech model. Parataxis Capital has completed 2 acquisitions, including Bridge Biotherapeutics and Strix Leviathan. Parataxis Capital offers products and services including Digital Asset Investment Advisory. Its focus areas include Financials, Investment Management and Digital Asset Investment.
Company details
Parataxis Capital Management LLC is engaged in providing multi-strategy investment advisory services within the digital asset sector. The firm is composed of a team with extensive experience in traditional financial markets and digital assets, emphasizing disciplined risk management. Services are tailored for institutional allocators, family offices, and high-net-worth individuals, aiming to deliver uncorrelated and risk-managed exposure to the digital asset ecosystem. The approach is supported by leveraging market inefficiencies and employing diverse investment strategies across market cycles.
- Headquarters New York, United States
- SectorsFinancial Services
- Email••••••••
- Website parataxis.io
- Social LinkedIn
- Investments & AcquisitionsBridge Biotherapeutics
& 1 more
Products & Services of Parataxis Capital
Parataxis Capital offers a comprehensive portfolio of products and services, including Digital Asset Investment Advisory.
Investment advisory services are provided for digital assets.
People of Parataxis Capital
2 people are tracked at Parataxis Capital (2 in leadership).
| Name | Role | Group |
|---|---|---|
Thejas Nalval | Co-founder & Co-cio | Leadership |
Lalita Chelluri | COO & Head Of Investor Relations | Leadership |
Complete people profiles for Parataxis Capital
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Parataxis Capital
Parataxis Capital has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Bridge Biotherapeutics and Strix Leviathan.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Small molecule therapeutics are developed for treating various diseases. | bridgebiorx.com | Seongnam-si, South Korea | 2015 | Jun 2025 | $18.11M | |
Crypto investment platform for institutional investors | strixleviathan.com | Seattle, United States | 2018 | Feb 2025 | •••• |
Complete acquisition details for Parataxis Capital
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Parataxis Capital
3 dated milestones of Parataxis Capital across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Parataxis Capital is founded.
- Acquisition Acquires Strix Leviathan.
- Acquisition Acquires Bridge Biotherapeutics.
Top companies in Investment & Wealth Tech
3 companies that operate in the same segment as Parataxis Capital (Investment & Wealth Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cloud-based website builder tool | 2003 | New York, New York, United States | USD 591.5 M | USD 16.79 M | 2,161 | |
Alternative investment platform for startups and investors is operated. | 2010 | San Francisco, California, United States | USD 100 M | 523 | ||
Web3 infrastructure solutions are offered via a blockchain platform. | 2021 | Palo Alto, California, United States | USD 336 M | 186 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Parataxis Capital
Complete news archive for Parataxis Capital
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parataxis Capital
Parataxis Capital was founded in 2019.
Parataxis Capital is headquartered in New York, United States. It is registered at New York, New York, United States.
Parataxis Capital Management LLC is engaged in providing multi-strategy investment advisory services within the digital asset sector. The firm is composed of a team with extensive experience in traditional financial markets and digital assets, emphasizing disciplined risk management. Services are tailored for institutional allocators, family offices, and high-net-worth individuals, aiming to deliver uncorrelated and risk-managed exposure to the digital asset ecosystem. The approach is supported by leveraging market inefficiencies and employing diverse investment strategies across market cycles.
Parataxis Capital offers Digital Asset Investment Advisory.
Parataxis Capital has made 2 acquisitions, including Bridge Biotherapeutics, and Strix Leviathan.